Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Apr;17(4):730–731. doi: 10.1128/aac.17.4.730

Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.

C N Walker
PMCID: PMC283860  PMID: 6772095

Abstract

Vancomycin determinations were performed in the presence of an aminoglycoside or rifampin. A previously reported bioassay method was modified by using a rifampin-resistant strain and increasing the NaCl concentration in the minimal salts-glucose assay agar from 0.2 to 6.0%.

Full text

PDF
730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook F. V., Farrar W. E., Jr Vancomycin revisited. Ann Intern Med. 1978 Jun;88(6):813–818. doi: 10.7326/0003-4819-88-6-813. [DOI] [PubMed] [Google Scholar]
  2. Faville R. J., Jr, Zaske D. E., Kaplan E. L., Crossley K., Sabath L. D., Quie P. G. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA. 1978 Oct 27;240(18):1963–1965. doi: 10.1001/jama.240.18.1963. [DOI] [PubMed] [Google Scholar]
  3. Geraci J. E. Vancomycin. Mayo Clin Proc. 1977 Oct;52(10):631–634. [PubMed] [Google Scholar]
  4. Harwick H. J., Kalmanson G. M., Guze L. B. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob Agents Chemother. 1973 Oct;4(4):383–387. doi: 10.1128/aac.4.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hook E. W., 3rd, Roberts R. B., Sande M. A. Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1975 Nov;8(5):564–570. doi: 10.1128/aac.8.5.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mandell G. L., Lindsey E., Hook E. W. Synergism of vancomycin and streptomycin for enterococci. Am J Med Sci. 1970 May;259(5):346–349. doi: 10.1097/00000441-197005000-00006. [DOI] [PubMed] [Google Scholar]
  7. Tuazon C. U., Lin M. Y., Sheagren J. N. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1978 May;13(5):759–761. doi: 10.1128/aac.13.5.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Walker C. A., Kopp B. Sensitive bioassay for vancomycin. Antimicrob Agents Chemother. 1978 Jan;13(1):30–33. doi: 10.1128/aac.13.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Watanakunakorm C., Glotzbecker C. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother. 1974 Dec;6(6):802–806. doi: 10.1128/aac.6.6.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Watanakunakorn C., Glotzbecker C. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci. J Med Microbiol. 1977 Feb;10(1):133–138. doi: 10.1099/00222615-10-1-133. [DOI] [PubMed] [Google Scholar]
  11. Westenfelder G. O., Paterson P. Y., Reisberg B. E., Carlson G. M. Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA. 1973 Jan 1;223(1):37–40. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES